Amalgamated Bank’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,469
Closed -$8K 3177
2023
Q1
$8K Sell
6,469
-628
-9% -$1.15K ﹤0.01% 2854
2022
Q4
$19K Hold
7,097
﹤0.01% 2771
2022
Q3
$20K Hold
7,097
﹤0.01% 2821
2022
Q2
$35K Sell
7,097
-833
-11% -$4.36K ﹤0.01% 2648
2022
Q1
$56K Buy
+7,930
New +$65.6K ﹤0.01% 2432
2021
Q3
Sell
-9,055
Closed -$406K 2185
2021
Q2
$406K Buy
+9,055
New +$420K ﹤0.01% 1744

Other funds holding CELL

Amalgamated Bank's CELL Position: Q2 2023 in Review

Amalgamated Bank sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 6,469 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in CELL in Q2 2021 and held it in 6 quarters. The position peaked at $406K in Q2 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Amalgamated Bank reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 6,469 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $8K.
  • Amalgamated Bank first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Amalgamated Bank's PhenomeX Inc. Common Stock position peaked at $406K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.